No Detail Found!

Anti-pandemic influenza A (H1N1) virus potential of Xilingjiedu capsule in vitro

Author(s)
Xiao-Yan Liu State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Peking University,Beijing,PR China
Gui-Yun Cao Institute of Traditional Chinese Medicine Shandong Hongjitang Pharmaceutical Group Co., Ltd.,Jinan,PR China
Yi Luo Institute of Traditional Chinese Medicine Shandong Hongjitang Pharmaceutical Group Co., Ltd.,Jinan,PR China
Zhao-Qing Meng Institute of Traditional Chinese Medicine Shandong Hongjitang Pharmaceutical Group Co., Ltd.,Jinan,PR China
You-Bo Zhang State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Peking University,Beijing,PR China
Abstract
This study is aimed to investigate the effect of Xilingjiedu capsule (XLC), one of a preparation of traditional Chinese medicine, on influenza A (H1N1) virus as well as its preliminary mechanism. The median cell mortality (TC50) to A549 cells and half effective inhibition concentration (IC50) of influenza A (H1N1) virus of XLC were determined by MTT assay. Reed-Muench method was used to calculated the 50% tissue culture infective dose (TCID50) of H1N1 virus to A549 cells. In mechanism research, the mRNA expression levels of MyD88, TLR4, TLR7 and TRAF6 and the protein expression level of MyD88 were detected by using RT-PCR and Western blot, respectively. The results suggested that XLC showed good anti influenza A (H1N1) virus activity. The antiviral mechanism of XLC was related to the Toll-like signaling pathway. It could drown regulate the mRNA expression level of MyD88 and TLR4 and the protein level of MyD88. This research provides reference for the application of XLC in anti influenza virus.
Publication Details
Page(s) 123-128
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
mRNA Expression, XLC, influenza A (H1N1) virus, A549 cells
References
Ahn DG,Shin HJ,Kim MH,Lee S,Kim HS,Myoung J,Kim BT,Kim SJ,Microbiol SJ .2020 .Current status of epidemiology, diagnosis, therapeutics and vaccines for novel coronavirus disease 2019 (COVID-19). , 30(3) : 313-324.
Al Khatib HA,Al Thani AA,Yassine HM .2018 .Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017. , 163(11) : 3035-3049.
Chen Q,Wu Y,Qi XY,Xuan ZN,Chen XM .2016 .Progress on traditional Chinese medicine treatment of influenza A(H1N1). Progr. Modern Biomed, 16(19) : 3793-3796.
Dai W,Chen J,Lu P,Gao YB,Chen L,Liu X,Song JL,Xu HY,Chen D,Yang YP,Yang HJ,Huang LQ .2013 .Pathway pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula. Mol. Biosyst, 9(3) : 375-385.
Ding Y,Cao Z,Cao L,Ding G,Wang ZH,Xiao W .2017 .Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase. Sci. Rep, 7 : 45723.
Duan ZP,Jia ZH,Zhang J,Liu S,Chen Y,Liang LC,Zhang CQ,Zhang Z,Sun Y,Zhang SQ,Wang YY,Wu YL .2011 .Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial. Chin. Med. J, 124(18) : 2925-2933.
Geng ZG .2000 .Xiilingjiedu tablets for the treatment of oral ulcer. China's Naturopathy, 8(1) : 43.
Hamilton K .2009 .The emergence of the pandemic A/H1N1 2009 virus and its characteristics. Bull. Mem. Acad. R. Med, 164(10) : 260-263.
He WY,Gao RM,Li XQ,Jiang JD,Li YH .2010 .In vitro anti-influenza virus activity of 10 traditional Chinese medicines. Acta. Pharm. Sin, 45(3) : 395-398.
Hu YG,Wang YT,Yu XF,Shi HY .2013 .Qualitative and quantitative study of compound Xiling Jiedu pills. , 11(08) : 619-621.
Kou Z,Hu SN,Li TX .2009 .Genome evolution of novel influenza A (H1N1) viruses in humans. Chin. Sci. Bull, 54(12) : 1652-1656.
Li C,Dai Y,Zhang SX,Duan YH,Liu ML,Chen LY,Yao XS .2014 .Quinoid glycosides from Forsythia suspensa. Phytochemistry, 104 : 105-113.
Li RF,Hou YL,Huang JC,Pan WQ,Ma QH,Shi YX,Li CF,Zhao J,Jia ZH,Jiang HM,Zheng K,Huang SX,Dai J,Li XB,Hou XT,Wang L,Zhong NS,Yang ZF .2020 .Lianhuaqingwen exerts anti-viral and antiinflammatory activity against novel coronavirus (SARS-CoV-2. Pharmacol. Res., 20 : 104761.
Li YT,Xie JF,Zheng KC .2015 .Advances in molecular epidemiology of influenza a (H1N1) virus. Straits J. Prevent. Med, 21(2) : 20-24.
Li Z,Zhao J,Zhou H,Li L,Ding YY,Li J,Zhou BX,Jiang HM,Zhong NS,Hu WH,Yang ZF .2018 .Cappariloside A shows antiviral and better antiinflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo. Life Sci, 200 : 115-125.
Liu XY,Liu S,Li Y,Gu LG,Liu XT,Du H XT .2016 .Study on anti-influenza virus H1N1 activity of microemulsion extract of compound Longqincao in vitro. Tianjin J. TCM., 33(3) : 172-176.
Michaelis M,Doerr HW,Cinatl Jr J .2009 .An influenza A H1N1 virus revival pandemic H1N1/09 virus. , 37(5) : 381-389.
Smith GJ,Vijaykrishna D,Bahl J,Lycett SJ,Worobey M,Pybus OG,Ma SK,Cheung CL,Raghwani J,Bhatt S,Peiris JSM,Guan Y,Rambaut A .2009 .Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 459(7250) : 1122-1125.
Shi PH,Qu XY,Zhou Z,Huang X .2017 .Research progress of Chinese medicine compound against influenza virus. Chin. J. Tradit. Chin. Med, 32(3) : 1172-1175.
Shi XH .2011 .Determination of forsythia glycoside in compound xiling jiedu tablets by HPLC. J. Shandong Chin. Med, 30(8) : 573-575.
Stertz S,Harris M .2018 .A novel mutation in the neuraminidase gene of the 2009 pandemic H1N1 influenza A virus confers multidrug resistance. J. Gen. Virol., 99(3) : 275-276.
Sun C,Tian YF,Yuan ML,Cao X,Pan NN .2015 .Study on quality standard of compound Xiling Jiedu capsules. Food Drug, 17(3) : 187-189.
Velavan TP,Meyer CG .2020 .. The COVID-19 epidemic. Trop. Med. Int. Health, 25(3) : 278-280.
Wang M,Qiu ZJ,Chen XH .2020 .Research progress of traditional Chinese medicine in treating influenza. J. Emerg. Tradit. Chin. Med, 29(3) : 558-561.
Wei TJ,Wang Y,Chen XD Y .2014 .Determination of orientin, isoorientin, vitexin and pulegone. Chin. Tradit. Patent Med, 36(11) : 2316-2319.
Wei WY,Wan HT,Yu L,Lu YY,He Y .2018 .Effect and mechanism of Mahuang Tang against influenza A/H1N1 virus in vitro. Chin. J. Chin. Meter. Med, 43(3) : 563-570.
Zhang XX,Wu QF,Yan YL,Zhang FL .2018 .Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus. Inflamm. Res., 67(2) : 179-189.
0

Citations

0

Downloads

171

Views